Showing results (71-80 of 203) with videos related to
Sort By:
Pageof 21
Drugs|April 20, 2006
Advances in the treatment of testicular cancerHans-Georg Kopp, Markus Kuczyk, Johannes Classen, et al.Transplantation|March 30, 2002
Sustained remission of an extensive monoclonal, Epstein-Barr virus-associated diffuse large B cell lymphoma in a kidney-pancreas transplant recipientMarkus G Manz, Christoph Berger, Hans-Peter Horny, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2003
Prognostic value of minimal residual disease quantification by real-time reverse transcriptase polymerase chain reaction in patients with core binding factor leukemiasJürgen Krauter, Kerstin Gorlich, Oliver Ottmann, et al.Annals of Neurology|June 2, 2005
NOA-03 trial of high-dose methotrexate in primary central nervous system lymphoma: final reportUlrich Herrlinger, Wilhelm Küker, Martin Uhl, et al.Anticancer Research|July 1, 2015
Death Receptor Expression on Blasts in AML Is Associated with Unfavorable PrognosisJoerg Uwe Schmohl, Tina Nuebling, Julia Wild, et al.Transfusion|April 19, 2002
Human plasma thrombopoietin levels are regulated by binding to platelet thrombopoietin receptors in vivoStefan Scheding, Markus Bergmann, Akihiro Shimosaka, et al.Journal of Cancer Research and Clinical Oncology|August 15, 2019
The role of autologous stem cell transplantation in peripheral T cell lymphoma: a long-term follow-up single-center experienceMalte Roerden, Juliane S Walz, Martin R Müller, et al.Cancer|May 17, 2002
Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography with conventional assessment by computed tomography scans and serum tumor markers for the evaluation of residual masses in patients with nonseminomatous germ cell carcinomaChristian Kollmannsberger, Karin Oechsle, Bernhard M Dohmen, et al.Onkologie|September 15, 2005
Disseminated epitheloid hemangioendothelioma mimicking symptoms of systemic vasculitisMichael Haap, Ina Kötter, Marius Horger, et al.BMC Cancer|January 18, 2016
Dronabinol has preferential antileukemic activity in acute lymphoblastic and myeloid leukemia with lymphoid differentiation patternsKerstin Maria Kampa-Schittenhelm, Olaf Salitzky, Figen Akmut, et al.Pageof 21